Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Hoffman

Showing results (81-90 of 204) with videos related to

Pageof 21
Sort By:
Blood|December 15, 2025
Microenvironmental cell interactions are essential for sustaining functionality of myelofibrosis malignant stem cellsMin Lu, Md Babu Mia, Lijuan Xia, et al.
Cancer Research|October 28, 2016
Alox5 Blockade Eradicates JAK2V617F-Induced Polycythemia Vera in MiceYaoyu Chen, Yi Shan, Min Lu, et al.
Blood|July 14, 2010
Treatment with the Bcl-xL inhibitor ABT-737 in combination with interferon α specifically targets JAK2V617F-positive polycythemia vera hematopoietic progenitor cellsMin Lu, Jiapeng Wang, Yan Li, et al.
Psychosomatics|December 25, 2016
Psychological Manifestations of Early Childhood Adversity in the Context of Chronic Hematologic MalignancyDaniel C McFarland, Megan Johnson Shen, Heather Polizzi, et al.
Psychosomatics|October 18, 2016
Preferences of Patients With Myeloproliferative Neoplasms for Accepting Anxiety or Depression TreatmentDaniel C McFarland, Megan Johnson Shen, Heather Polizzi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 5, 2009
Use of molecular testing to identify a cluster of patients with polycythemia vera in eastern PennsylvaniaVincent Seaman, Aisha Jumaan, Emad Yanni, et al.
Psychosomatics|March 7, 2018
Associations of Physical and Psychologic Symptom Burden in Patients With Philadelphia Chromosome-Negative Myeloproliferative NeoplasmsDaniel C McFarland, Kelly M Shaffer, Heather Polizzi, et al.
Blood|September 23, 2010
Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cellsXiaoli Wang, Wei Zhang, Joseph Tripodi, et al.
Blood|February 7, 2009
Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disordersTakefumi Ishii, Jiapeng Wang, Wei Zhang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2017
Prevalence of Physical Problems Detected by the Distress Thermometer and Problem List in Patients With Myeloproliferative DisordersDaniel C McFarland, Kelly M Shaffer, Heather Polizzi, et al.
Pageof 21

Showing results (81-90 of 204) with videos related to

Sort By:
Pageof 21
Blood|December 15, 2025
Microenvironmental cell interactions are essential for sustaining functionality of myelofibrosis malignant stem cellsMin Lu, Md Babu Mia, Lijuan Xia, et al.
Cancer Research|October 28, 2016
Alox5 Blockade Eradicates JAK2V617F-Induced Polycythemia Vera in MiceYaoyu Chen, Yi Shan, Min Lu, et al.
Blood|July 14, 2010
Treatment with the Bcl-xL inhibitor ABT-737 in combination with interferon α specifically targets JAK2V617F-positive polycythemia vera hematopoietic progenitor cellsMin Lu, Jiapeng Wang, Yan Li, et al.
Psychosomatics|December 25, 2016
Psychological Manifestations of Early Childhood Adversity in the Context of Chronic Hematologic MalignancyDaniel C McFarland, Megan Johnson Shen, Heather Polizzi, et al.
Psychosomatics|October 18, 2016
Preferences of Patients With Myeloproliferative Neoplasms for Accepting Anxiety or Depression TreatmentDaniel C McFarland, Megan Johnson Shen, Heather Polizzi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 5, 2009
Use of molecular testing to identify a cluster of patients with polycythemia vera in eastern PennsylvaniaVincent Seaman, Aisha Jumaan, Emad Yanni, et al.
Psychosomatics|March 7, 2018
Associations of Physical and Psychologic Symptom Burden in Patients With Philadelphia Chromosome-Negative Myeloproliferative NeoplasmsDaniel C McFarland, Kelly M Shaffer, Heather Polizzi, et al.
Blood|September 23, 2010
Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cellsXiaoli Wang, Wei Zhang, Joseph Tripodi, et al.
Blood|February 7, 2009
Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disordersTakefumi Ishii, Jiapeng Wang, Wei Zhang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2017
Prevalence of Physical Problems Detected by the Distress Thermometer and Problem List in Patients With Myeloproliferative DisordersDaniel C McFarland, Kelly M Shaffer, Heather Polizzi, et al.
Pageof 21